SREBF2 and metabolic dysfunction-associated steatohepatitis: Musso et al. reviewed cellular mechanisms of cholesterol toxicity involved in liver injury and NASH and highlighted the therapeutic impact of anthocyanin through a decrease SREBP2 and lipogenesis [104].